ES2155223T3 - 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. - Google Patents
1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.Info
- Publication number
- ES2155223T3 ES2155223T3 ES97108012T ES97108012T ES2155223T3 ES 2155223 T3 ES2155223 T3 ES 2155223T3 ES 97108012 T ES97108012 T ES 97108012T ES 97108012 T ES97108012 T ES 97108012T ES 2155223 T3 ES2155223 T3 ES 2155223T3
- Authority
- ES
- Spain
- Prior art keywords
- well
- naftoilguanidins
- employment
- substituted
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LA INVENCION TRATA DE 1 IONADOS EN LAS REIVINDICACIONES. ESTOS COMPUESTOS, COMO MEDICAMENTOS ANTIARRITMICOS CON COMPONENTE CARDIOPROTECTOR, SON IDONEOS PARA LA PROFILAXIS DEL INFARTO Y PARA EL TRATAMIENTO DEL MISMO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA DE PECHO. TAMBIEN INHIBEN DE FORMA PREVENTIVA LOS PROCESOS PATOFISIOLOGICOS EN CASO DE DAÑOS INDUCIDOS POR ISQUEMIA, EN PARTICULAR EN EL CASO DE ARRITMIAS CARDIACAS INDUCIDAS POR ISQUEMIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19621482A DE19621482A1 (de) | 1996-05-29 | 1996-05-29 | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2155223T3 true ES2155223T3 (es) | 2001-05-01 |
Family
ID=7795548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97108012T Expired - Lifetime ES2155223T3 (es) | 1996-05-29 | 1997-05-16 | 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
Country Status (29)
Country | Link |
---|---|
US (1) | US6600072B2 (es) |
EP (1) | EP0810205B1 (es) |
JP (1) | JP4039587B2 (es) |
KR (1) | KR970074753A (es) |
CN (1) | CN1062859C (es) |
AR (1) | AR007299A1 (es) |
AT (1) | ATE200076T1 (es) |
AU (1) | AU710258B2 (es) |
BR (1) | BR9703342A (es) |
CA (1) | CA2206362C (es) |
CZ (1) | CZ292441B6 (es) |
DE (2) | DE19621482A1 (es) |
DK (1) | DK0810205T3 (es) |
ES (1) | ES2155223T3 (es) |
GR (1) | GR3035811T3 (es) |
HR (1) | HRP970294B1 (es) |
HU (1) | HUP9700954A3 (es) |
ID (1) | ID17348A (es) |
IL (1) | IL120925A0 (es) |
NO (1) | NO308528B1 (es) |
NZ (1) | NZ314914A (es) |
PL (1) | PL185755B1 (es) |
PT (1) | PT810205E (es) |
RU (1) | RU2182901C2 (es) |
SI (1) | SI0810205T1 (es) |
SK (1) | SK282356B6 (es) |
TR (1) | TR199700427A2 (es) |
TW (1) | TW372955B (es) |
ZA (1) | ZA974664B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10023405A1 (de) * | 2000-05-12 | 2001-11-15 | Merck Patent Gmbh | Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen |
PE20040167A1 (es) * | 2002-03-28 | 2004-05-26 | Novartis Ag | Amidas del acido sulfamico |
CA2508914A1 (en) | 2002-12-04 | 2004-06-17 | Gene Logic Inc. | Modulators of melanocortin receptor |
JP5030587B2 (ja) * | 2003-06-26 | 2012-09-19 | バイオトロン・リミテッド | 抗ウイルスアシルグアニジン化合物および方法 |
US20110118262A1 (en) * | 2008-07-08 | 2011-05-19 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4251545A (en) * | 1979-09-19 | 1981-02-17 | Gaf Corporation | Fungicidal process using 1-(alkoxyaroyl)guanidines |
DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
JPH08225513A (ja) * | 1994-12-21 | 1996-09-03 | Kanebo Ltd | ナフトイルグアニジン誘導体 |
JPH08225135A (ja) | 1995-02-21 | 1996-09-03 | Mitsubishi Heavy Ind Ltd | スクリユ−式土砂搬送機 |
DE19621483A1 (de) | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-05-29 DE DE19621482A patent/DE19621482A1/de not_active Withdrawn
-
1997
- 1997-02-28 PL PL97318724A patent/PL185755B1/pl not_active IP Right Cessation
- 1997-05-16 ES ES97108012T patent/ES2155223T3/es not_active Expired - Lifetime
- 1997-05-16 PT PT97108012T patent/PT810205E/pt unknown
- 1997-05-16 DK DK97108012T patent/DK0810205T3/da active
- 1997-05-16 EP EP97108012A patent/EP0810205B1/de not_active Expired - Lifetime
- 1997-05-16 DE DE59703220T patent/DE59703220D1/de not_active Expired - Lifetime
- 1997-05-16 AT AT97108012T patent/ATE200076T1/de not_active IP Right Cessation
- 1997-05-16 SI SI9730125T patent/SI0810205T1/xx unknown
- 1997-05-27 AR ARP970102252A patent/AR007299A1/es unknown
- 1997-05-27 NZ NZ314914A patent/NZ314914A/en unknown
- 1997-05-27 CZ CZ19971631A patent/CZ292441B6/cs not_active IP Right Cessation
- 1997-05-27 IL IL12092597A patent/IL120925A0/xx not_active IP Right Cessation
- 1997-05-27 CN CN97113186A patent/CN1062859C/zh not_active Expired - Fee Related
- 1997-05-27 AU AU23713/97A patent/AU710258B2/en not_active Ceased
- 1997-05-27 HR HR970294A patent/HRP970294B1/xx not_active IP Right Cessation
- 1997-05-27 TR TR97/00427A patent/TR199700427A2/xx unknown
- 1997-05-27 HU HU9700954A patent/HUP9700954A3/hu unknown
- 1997-05-27 TW TW086107121A patent/TW372955B/zh active
- 1997-05-27 SK SK669-97A patent/SK282356B6/sk unknown
- 1997-05-28 KR KR1019970021106A patent/KR970074753A/ko not_active Application Discontinuation
- 1997-05-28 NO NO972434A patent/NO308528B1/no not_active IP Right Cessation
- 1997-05-28 RU RU97109002/04A patent/RU2182901C2/ru not_active IP Right Cessation
- 1997-05-28 CA CA002206362A patent/CA2206362C/en not_active Expired - Fee Related
- 1997-05-28 JP JP13822697A patent/JP4039587B2/ja not_active Expired - Fee Related
- 1997-05-28 ZA ZA9704664A patent/ZA974664B/xx unknown
- 1997-05-28 ID IDP971813A patent/ID17348A/id unknown
- 1997-05-30 BR BR9703342A patent/BR9703342A/pt not_active IP Right Cessation
-
2001
- 2001-04-30 GR GR20010400659T patent/GR3035811T3/el not_active IP Right Cessation
-
2002
- 2002-08-14 US US10/217,457 patent/US6600072B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2093979T3 (es) | Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion. | |
CR6592A (es) | Compuestos para el tratamiento de la isquemia | |
ES2179351T3 (es) | Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores. | |
MX9304432A (es) | Compuestos y formulaciones farmaceuticas para el tratamiento o prevencion de la osteoporosis y la perdida de los huesos. | |
GT199900070A (es) | Derivados de isotiazol, utiles como agentes anticancerosos. | |
AR004253A1 (es) | Sulfonimidoamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamento quelas contiene. | |
MX9306234A (es) | Oxindoles y azaoxoindoles 1-substituidos y composiciones farmaceuticas que los contienen. | |
ES2159403T3 (es) | Poliuretanos termoplasticos que contienen principios activos. | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
ES2154002T3 (es) | 2-naftoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
BRPI0107493B8 (pt) | substâncias para uso no tratamento de psoríase | |
ES2178761T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas. | |
ES2155223T3 (es) | 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
ES2166487T3 (es) | Benzoil-guanidinas sustituidas en posicion orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
ES2167721T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica. | |
ES2196456T3 (es) | Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen. | |
AR011860A1 (es) | Preparado de combinacion para la aplicacion en la demencia, un procedimiento para su produccion y el empleo del mismo para la preparacionde un medicamento util para el tratamiento de enfermedades neurodegenerativas | |
AR028987A1 (es) | Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad | |
BR9712614A (pt) | Composição farmacêutica,processos para aumentar e manter a homogeneidade de uma composição farmac&eutica,para tratar,reverter,reduzir ou inibir infeccões retrovirais e para preparação de uma composição farmacêutica,uso de lamivudina ou de um derivado farmaceuticamenete aceitável da mesma,de zidovudina,ou de um derivado farmaceuticamente aceitável da mesma e de um agente de deslizamento farmaceuticamente aceitável,e, artigo de amnufatura. | |
ES2135811T3 (es) | Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras. | |
ES2175582T3 (es) | Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen. | |
ES2138359T3 (es) | Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales. | |
ES2148268T3 (es) | Composicion farmaceutica para prevenir o tratar fracturas de huesos. | |
AR004318A1 (es) | Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como elmedicamento que las contiene. | |
ES2170402T3 (es) | Derivados de benzo(g)quinolina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 810205 Country of ref document: ES |